Rongbin Ge

455 total citations
11 papers, 315 citations indexed

About

Rongbin Ge is a scholar working on Pulmonary and Respiratory Medicine, Urology and Molecular Biology. According to data from OpenAlex, Rongbin Ge has authored 11 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Urology and 3 papers in Molecular Biology. Recurrent topics in Rongbin Ge's work include Prostate Cancer Diagnosis and Treatment (7 papers), Urinary Bladder and Prostate Research (6 papers) and Urological Disorders and Treatments (3 papers). Rongbin Ge is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (7 papers), Urinary Bladder and Prostate Research (6 papers) and Urological Disorders and Treatments (3 papers). Rongbin Ge collaborates with scholars based in United States, China and Canada. Rongbin Ge's co-authors include Aria F. Olumi, Seth K. Bechis, Zongwei Wang, Chin‐Lee Wu, Shahin Tabatabaei, Libing Hu, Jijun Li, Morris F. White, Yinong Niu and Pablo Gómez and has published in prestigious journals such as PLoS ONE, Cancer Research and Diabetes.

In The Last Decade

Rongbin Ge

11 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongbin Ge United States 9 181 135 81 79 55 11 315
Anna Ciotkowska Germany 13 237 1.3× 125 0.9× 124 1.5× 48 0.6× 130 2.4× 27 386
Joanna K. Chon United States 8 173 1.0× 113 0.8× 67 0.8× 101 1.3× 116 2.1× 11 379
Pierre Costa France 5 113 0.6× 164 1.2× 71 0.9× 31 0.4× 180 3.3× 5 344
Toshihisa Tomoda Japan 11 84 0.5× 94 0.7× 66 0.8× 49 0.6× 33 0.6× 38 310
Ryoichi Yamagishi Japan 10 188 1.0× 63 0.5× 95 1.2× 34 0.4× 119 2.2× 17 368
A. Stuart Wright Canada 7 110 0.6× 216 1.6× 111 1.4× 24 0.3× 212 3.9× 9 380
Canqiao Luo China 9 27 0.1× 46 0.3× 83 1.0× 25 0.3× 48 0.9× 13 374
Libing Hu China 9 42 0.2× 73 0.5× 230 2.8× 15 0.2× 23 0.4× 12 366
H. Melchior Nissen Denmark 10 50 0.3× 101 0.7× 83 1.0× 54 0.7× 16 0.3× 19 295
Yujing Shu Japan 8 26 0.1× 26 0.2× 161 2.0× 13 0.2× 33 0.6× 13 346

Countries citing papers authored by Rongbin Ge

Since Specialization
Citations

This map shows the geographic impact of Rongbin Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongbin Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongbin Ge more than expected).

Fields of papers citing papers by Rongbin Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongbin Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongbin Ge. The network helps show where Rongbin Ge may publish in the future.

Co-authorship network of co-authors of Rongbin Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Rongbin Ge. A scholar is included among the top collaborators of Rongbin Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongbin Ge. Rongbin Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Zongwei, Tuo Deng, Xingbo Long, et al.. (2020). Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy. PLoS ONE. 15(3). e0229754–e0229754. 8 indexed citations
2.
Wang, Zongwei, Libing Hu, Keyan Salari, et al.. (2017). Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α‐reductase 2. The Journal of Pathology. 243(4). 457–467. 25 indexed citations
3.
Bechis, Seth K., Rongbin Ge, Zongwei Wang, et al.. (2015). Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia. The Journal of Urology. 194(4). 1031–1037. 28 indexed citations
4.
Ge, Rongbin, Zongwei Wang, Shulin Wu, et al.. (2015). Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells. Oncotarget. 6(30). 28973–28987. 20 indexed citations
5.
Ge, Rongbin, Zongwei Wang, Seth K. Bechis, et al.. (2015). DNA Methyl Transferase 1 Reduces Expression of SRD5A2 in the Aging Adult Prostate. American Journal Of Pathology. 185(3). 870–882. 24 indexed citations
6.
Jiang, Junjie, Jianquan Zhao, Xuhui Guo, et al.. (2015). Correlation between carbonic anhydrase IX (CA-9), XII (CA-12) and hypoxia inducible factor-2α (HIF-2α) in breast cancer. Neoplasma. 62(3). 456–463. 9 indexed citations
7.
Bechis, Seth K., et al.. (2014). Personalized Medicine for the Management of Benign Prostatic Hyperplasia. The Journal of Urology. 192(1). 16–23. 76 indexed citations
8.
Preston, Mark, Kathryn M. Wilson, Sarah C. Markt, et al.. (2014). 5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer. JAMA Internal Medicine. 174(8). 1301–1301. 30 indexed citations
9.
Ge, Rongbin, Zongwei Wang, & Aria F. Olumi. (2013). Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.. Cancer Research. 73(8_Supplement). 4965–4965. 1 indexed citations
10.
Wang, Zongwei, Zhiyong Cheng, Vivian Cristofaro, et al.. (2012). Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes. 61(8). 2134–2145. 61 indexed citations
11.
Niu, Yinong, Rongbin Ge, Libing Hu, et al.. (2011). Reduced levels of 5‐α reductase 2 in adult prostate tissue and implications for BPH therapy. The Prostate. 71(12). 1317–1324. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026